Back

Risk stratification in Brugada syndrome

19 March 2018 (12:07 - 12:30)
Organised by:
Congress Presentation Part of: Implication of basic insights for management of channelopathies Myocardial Disease EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Samuel Viskin

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

3 More presentations in this session

Presentation thumbnail
Interpretation of variants of unknown significance
Professor C. Bezzina (Amsterdam, NL)
Slides Video
Presentation thumbnail
Management of the catecholaminergic polymorphic ventricular tachycardia patient not protected by beta blockers
Doctor I. Denjoy (Paris, FR)
Slides Video
Presentation thumbnail
Precision medicine in long QT syndrome
Professor P. Schwartz (Milan, IT)
Slides Video

Access the full session

Session thumbnail
Implication of basic insights for management of channelopathies

The Event

Event poster

EHRA 2018

19 March 2018 12:07 CET
You may be interested in
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
31 March 2025
thumbnail
Congress Presentation
Electrophysiologic study for risk stratification in Brugada Syndrome: does it still matters?
27 August 2021
thumbnail
Congress Presentation
Genetic analysis and electrocardiographic patterns in Brugada syndrome
30 August 2025
thumbnail
Webinar
ACVC Biomarker Talk Series - Screening the general population - a role for cardiac biomarkers?
13 July 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources